Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Safety and efficacy of dulaglutide, a once weekly GLP-1 receptor agonist, for the management of type 2 diabetes
is not affiliated with or endorsed by these companies
Click here for the latest stock market news and in-depth analysis, including events that move stocks Read the latest financial and business news from Yahoo Finance
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Miller et al
SUSTAIN 7 compared semaglutide to Trulicity (dulaglutide), an already-available once-weekly GLP-1 agonist
To avoid identifying a species-specific effect, we also used MIN6B1 beta cells 22 and found a similar relationship between internalization and insulin release, albeit less marked (Fig
US$ 25.11
US$ 28.94
US$ 29.35
.png.jpg)
US$ 26.75
US$ 26.38
